Pieris Pharmaceuticals Inc (PIRS)
16.31
-0.17
(-1.03%)
USD |
NASDAQ |
Nov 08, 16:00
16.31
0.00 (0.00%)
After-Hours: 20:00
Pieris Pharmaceuticals Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 40.93M |
| December 31, 2023 | 42.81M |
| September 30, 2023 | 47.36M |
| June 30, 2023 | 33.21M |
| March 31, 2023 | 16.85M |
| December 31, 2022 | 25.90M |
| September 30, 2022 | 28.50M |
| June 30, 2022 | 27.19M |
| March 31, 2022 | 26.77M |
| December 31, 2021 | 31.42M |
| September 30, 2021 | 24.85M |
| June 30, 2021 | 23.73M |
| March 31, 2021 | 31.70M |
| December 31, 2020 | 29.32M |
| September 30, 2020 | 44.72M |
| June 30, 2020 | 56.91M |
| Date | Value |
|---|---|
| March 31, 2020 | 51.00M |
| December 31, 2019 | 46.28M |
| September 30, 2019 | 33.92M |
| June 30, 2019 | 27.14M |
| March 31, 2019 | 33.50M |
| December 31, 2018 | 29.10M |
| September 30, 2018 | 42.34M |
| June 30, 2018 | 37.92M |
| March 31, 2018 | 28.08M |
| December 31, 2017 | 25.28M |
| September 30, 2017 | 9.850M |
| June 30, 2017 | 6.708M |
| March 31, 2017 | 5.927M |
| December 31, 2016 | 5.831M |
| September 30, 2016 | 5.251M |
| June 30, 2016 | 4.873M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
16.85M
Minimum
Mar 2023
56.91M
Maximum
Jun 2020
34.97M
Average
31.56M
Median
Revenue (TTM) Benchmarks
| Ligand Pharmaceuticals Inc | 133.48M |
| NovaBay Pharmaceuticals Inc | 12.02M |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |